ERβ exerts multiple stimulative effects on human breast carcinoma cells

Oncogene

Volumn 23, Issue 34, 2004, Pages 5799-5806

  Hou, Yi Feng ^a   Yuan, Sheng Tao ^b   Li, He Cheng ^a   Wu, Jiong ^a   Lu, Jin Song ^a   Liu, Gang ^a   Lu, Li Juan ^a   Shen, Zhen Zhou ^a   Ding, Jian ^a,b   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Breast carcinoma; Estrogen receptor; Matrix metalloproteinases (MMPs)

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN RECEPTOR BETA; GELATINASE B; PROTEIN P21; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EST 1; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ETS1 PROTEIN, HUMAN; ETS1 PROTEIN, MOUSE; ONCOPROTEIN; TCEAL1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA TRANSFECTION; DOWN REGULATION; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; TUMOR XENOGRAFT; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL DIVISION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY;

ANIMALIA; MUS MUSCULUS;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 4143092547     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207765     Document Type: Article

References (33)

1. Albini A. (1998). Pathol. Oncol. Res., 4, 230-241.
2. Beato M, Hettlich P and Schutz G. (1995). Cell, 83, 851-857.
3. Bhat RA, Harnish DC, Stevis PE, Lyttle CR and Komm BS. (1988). J. Steroid Biochem. Mol. Biol., 67, 233-240.
4. Delsal G, Loda M and Pagano M. (1996). Crit. Rev. Oncog., 7, 127-142.
5. Dotslaw H, Leygue E, Watson PH and Murphy LC. (1997). J. Clin. Endocrinol. Metab., 82, 2371-2374.
6. Dotslaw H, Leygue E, Watson PH and Murphy LC. (1999). Cancer Res., 59, 529-532.
7. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M and Gustafsson JA. (1997). J. Clin. Endocrinol. Metab., 82, 4258-4265.
8. Folkman J. (1990). Cancer Metastasis Rev., 9, 171-174.
9. Haggitt RC. (1994). Hum. Pathol., 25, 982-993.
10. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K. (1995). Oncogene, 10, 1461-1463.
11. Hu YF, Lau KM, Ho SM and Russo J. (1998). Int. J. Oncol., 12, 1225-1228.
12. Iurlaro M, Loverro G, Vacca A, Cormio G, Ribatti D, Minischetti M, Ria R, Bruno M and Selvaggi L. (1999). Eur. J. Clin. Invest., 29, 793-801.
13. Irwin JC, Kirk D, Gwatkin RB, Navre M, Cannon P and Giudice LC. (1996). J. Clin. Invest., 97, 438-447.
14. Jarvinen TA, Pelto-Huikko M, Holli K and Isola J. (2000). Am. J. Pathol., 156, 29-35.
15. Kuiper GG, Enmark E, Pelto-Hhuikko M, Nilsson S and Gustafsson JA. (1996). Proc. Natl. Acad. Sci. USA, 93, 5925-5930.
16. Lazennec G, Bresson D, Lucas A, Chauveau C and Vignon F. (2001). Endocrinology, 142, 4120-4130.
17. Leygue E, Dotslaw H, Watson PH and Murphy LC. (1998). Cancer Res., 58, 3197-3201.
18. Leygue E, Watson PH and Murphy LC. (1997). J. Clin. Endocrinol. Metab., 82, 2371-2374.
19. Mizumoto H, Satto T, Ashihara K, Nishimura M, Tanaka R and Kudo R. (2002). Int. J. Cancer, 100, 401-406.
20. Moore JT, Mckee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM and Willson TM. (1998). Biochem. Biophys. Res. Commun., 247, 75-78.
21. Mosselman S, Polman J and Dijkema R. (1996). FEBS Lett., 392, 49-53.
22. Nakayama T, Ito M, Ohtsuru A, Naito S and Sekne I. (2001). Mod. Pathol., 14, 415-422.
23. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y and Muramatsu M. (1998). Biochem. Biophys. Res. Commun., 243, 122-126.
24. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, van Noorden S, Wahlstrom T, Coombes RC, Warner M and Gustafsson JA. (2002). Endocrine-Relat. Cancer., 9, 1-13.
25. Saeki H, Kuwano H, Kawaguchi H, Ohno S and Sugimachi K. (2000). Cancer, 89, 1670-1676.
26. Shao ZM, Nguyen M, Alpaugh ML, O'Connel JT and Barsky SH. (1998). Exp. Cell Res., 241, 394-403.
27. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D and Nguyen M. (2002). Int. J. Cancer, 98, 234-240.
28. Sherr CJ. (1996). Science, 274, 1672-1677.
29. Sillem M, Prifti S, Koumouridis A and Runnebaum B. (1999). Eur. J. Gynaecol. Oncol., 20, 367-370.
30. Tonetti DA, Rubenstein R, Deleon M, Zhao H, Pappas SG, Bentrem DJ, Chen B, Constantinou A and Jordan VC. (2003). J. Steroid Biochem. Mol. Biol., 87, 47-55.
31. Urquidi V, Sloan D, Kawai K, Agarwal D, Woodman AC, Tarin D and Goodison S. (2002). Clin. Cancer Res., 8, 61-74.
32. Van Golen KL, Risin S, Staroselsky A, Berger D, Tainsky MA, Pathak S and Price JE. (1996). Clin. Exp. Metastasis, 14, 95-106.
33. Wen XF, Shen Z, Shen ZZ, Nguyen M and Shao ZM. (2002). Oncol. Rep., 9, 937-944.